The significance of magnesium in insulin resistance, metabolic syndrome and diabetes - Recommendations of the Association of Magnesium Research e.V.;Die Bedeutung von Magnesium für Insulinresistenz, metabolisches Syndrom und Diabetes mellitus - Empfehlungen der Gesellschaft für Magnesium-Forschung e.V.

Diabetologie und Stoffwechsel

Volumn 9, Issue 2, 2014, Pages 96-100

  Von Ehrlich, B ^a   Barbagallo, M ^b   Classen, H G ^c   Guerrero Romero, F ^d   Mooren, F C ^e   Rodriguez Moran, M ^d   Vierling, W ^f   Vormann, J ^g   Kisters, K ^h  

^a Innere Medizin   (Germany)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF HOHENHEIM   (Germany)

^d INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^e JUSTUS LIEBIG UNIVERSITY   (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^g Inst fur Pravention und Ernahrung   (Germany)

^h ST ANNA HOSPITAL   (Germany)

Author keywords

diabetes mellitus; insulin resistance; magnesium

Indexed keywords

GLUCOSE; MAGNESIUM;

ARTICLE; CARBOHYDRATE METABOLISM; DETERIORATION; DIABETES MELLITUS; DIABETIC PATIENT; ENDOTHELIUM; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; KIDNEY FUNCTION; MAGNESIUM BLOOD LEVEL; MAGNESIUM DEPLETION; MAGNESIUM METABOLISM; METABOLIC SYNDROME X; RETINOPATHY; STRESS;

EID: 84900391278     PISSN: 18619002     EISSN: 18619010     Source Type: Journal    
DOI: 10.1055/s-0034-1366398     Document Type: Article

References (62)

1. Von Ehrlich B., Barbagallo M., Classen H. G. et al. Leitlinie Magnesium und Diabetes. Nieren-Hochdruckkrkh: 2009; 38 633 635
2. ESC-Guideline: Guidelines for the management of atrial fibrillation. Eur Heart J: 2010; 31 2369 2429
3. Barbagallo M., Dominguez L. J. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys: 2007; 458 40 47 (Pubitemid 46186226)
4. Barbagallo M., Dominguez L. J., Galioto A. et al. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Asp Med: 2003; 24 39 52 (Pubitemid 36092143)
5. Resnick L. M., Gupta R. K., Gruenspan H. et al. Hypertension and peripheral insulin resistance. Possible mediating role of interacellular free magnesium. Am J Hypertens: 1990; 3 373 379 (Pubitemid 20188289)
6. Xu J., Xu W., Yao H. et al. Association of serum and urinary magnesium with the pre-diabetes, diabetes and diabetic complications in the chinese northeast population. PLOS ONE: 2013; 8 online publication
7. Huang J. H., Lu Y. F., Cheng F. C. et al. Correlation of magnesium intake with metabolic parameters, depression and physical activity in elderly type II diabetes patients: a cross-sectional study. Nutrition Journal: 2012; 11 41 51
8. Corica F., Corsonello A., Ientile R. et al. Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients. J Am Coll Nutr: 2006; 25 210 215 (Pubitemid 46939845)
9. Takaya J., Higashino H., Kotera F. et al. Intracellular magnesium of platelets in children with diabetes and obesity. Metabolism: 2003; 52 468 471 (Pubitemid 36773269)
10. Wälti M. K., Zimmermann M. B., Spinas A. et al. Low plasma magnesium in type 2 diabetes. Swiss Med Wkly: 2003; 133 289 292 (Pubitemid 36858482)
11. Sjögren A., Floren C. H., Nilsson A. Magnesium deficiency in IDDM related to level of glycosylated hemoglobin. Diabetes: 1986; 35 459 463 (Pubitemid 16078459)
12. Huerta M. G., Roemmich J. N., Kington M. L. et al. Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care: 2005; 28 1175 1181 (Pubitemid 40616631)
13. Rosolova H., Mayer O., Reaven G. M. Insulin-mediated glucose disposal is decreased in normal subjects with relatively low plasma magnesium concentrations. Metabolism: 2000; 49 418 420 (Pubitemid 30146576)
14. Ma J., Folsom A. R., Melnick S. L. et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes insulin and carotid arterial wall thickness: The ARIC study. J Clin Epidemiol: 1995; 48 927 940
15. He K., Liu K., Daviglus M. L. et al. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation: 2006; 113 1675 1682
16. Rumawas M. E., McKeown N. M., Rogers G. et al. Magnesium intake is related to improved insulin homeostasis in the Framingham Offspring Cohort. J Am Coll Nutr: 2006; 25 486 492 (Pubitemid 46175664)
17. Rodriguez-Moran M., Gerrero-Romero F. Insulin secretion is decreased in non-diabetic individuals with hypomagnesiaemia. Diabetes Metab Res Rev: 2011; 27 590 596
18. Paolisso G., Scheen A., Cozzolino D. et al. Changes in glucose turnover parameters and improvenet of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J Clin Endocrinol Metab: 1994; 78 1510 1514
19. Paolisso G., Passariello N., Pizza G. et al. Dietary magnesium supplements improve B-cell response to glucose and arginine in elderly non-insulin dependent diabetic subjects. Acta Endocr: 1989; 121 16 20 (Pubitemid 19167525)
20. Weng L. C., Lee N. J., Yeh W. T. et al. Lower intake of magnesium and dietary fiber increases the incidence of type 2 diabetes in Taiwanese. J Form Med Assoc: 2012; 111 651 659
21. Guerrero-Romero F., Rascon-Pacheco R. A., Rodriguez-Moran M. et al. Hypomagnesaemia and risk for metabolic glucose disorders: a 10-year follow-up study. Eur J Clin Invest: 2008; 38 389 396 (Pubitemid 351712929)
22. Larsson S. C., Wolk A. Magnesium intake and risk of type 2 diabetes: a meta-analysis. J Intern Med: 2007; 262 208 214 (Pubitemid 47087634)
23. Van Dam R. M., Hu F. B., Rosenberg L. et al. Dietary calcium and magnesium, major food sources, an risk of type 2 diabetes in U. S. Black Women. Diabetes Care: 2006; 29 2238 2243 (Pubitemid 44899858)
24. Lopez-Ridaura R., Willett W. C., Rimm E. B. et al. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care: 2004; 27 134 140 (Pubitemid 38196722)
25. Song Y., Manson J. E., Buring J. E. et al. Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care: 2004; 27 59 65 (Pubitemid 38196710)
26. Kao W. HL, Folsom A. R., Nieto F. J. et al. Serum and dietary magnesium and the risk for type 2 diabetes mellitus. Arch Intern Med: 1999; 159 2151 2159
27. Dong J. Y., Xun P., He K. et al. Magnesium intake an risk of type 2 diabetes. Diabetes care: 2011; 34 2116 2112
28. Bardicef M., Bardicef O., Sorokin Y. et al. Extracellular and intracellular magnesium depletion in pregnancy and gestational diabetes. Am J. Obstet Gynecol: 1995; 172 1009 1013
29. Speich M., Murat A., Classen H. G. et al. Longitudinal study of concentrations of plasma, erythrocyte and urine magnesium, calcium, phosphorus, potassium, zinc and copper during insulin-dependent diabetic pregnancy. Mag Bull: 1993; 15 39 43
30. Kleinwechter H., Schäfer-Graf U., Bührer C. et al. Gestationsdiabetes mellitus (GDM) - Diagnostik, Therapie u. Nachsorge. Diabetologie: 2012; 7 S174 S184
31. Jose B., Jain V., Vikram N. K. et al. Serum Magnesium in overweight children. Indian pediatrics: 2012; 49 109 112
32. Celik N., Andiran N., Yilmaz A. E. The relationship between serum magnesium levels with childhood obesity and insulin resistance: a review of the literature. J Pediatr Endocrinol Metab: 2011; 24 09 675 678
33. Mooren F. C., Krüger K., Völker K. et al. Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial. Diabetes Obes Metab: 2011; 13 281 284
34. Hadjistavri L. S., Sarafidis P. A., Georgianos P. I. et al. Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile. Med Sci Monit: 2010; 16 13 18
35. Guerrero-Romero F., Tamez-Perez H. E., Gonzalez-Gonzalez G. et al. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab: 2004; 30 253 258 (Pubitemid 38917455)
36. Rodriguez-Moran M., Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects. Diabetes Care: 2003; 26 1147 1152 (Pubitemid 36929263)
37. Song Y., He K., Levitan E. B. et al. Effects of oral magnesium supplementation on glycaemic control in type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabet Med: 2006; 23 1050 1056 (Pubitemid 44401132)
38. Liao F., Folsom A. R., Brancati F. L. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J: 1998; 136 480 490 (Pubitemid 28413547)
39. Barbagallo M., Dominguez L. J., Galioto A. et al. Oral magnesium supplementation improves vascular function in elderly diabetic patients. Mag Res: 2010; 23 131 137
40. Rasheed H., Elahi S., Ajaz H. Serum magnesium and atherogenic lipid fractions in type II diabetic patients of Lahore, Pakistan. Biol Trace Elem Res: 2012; 148 165 169
41. Guerrero-Romero F., Rodriguez-Moran M. Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values. J Diabetes Complications: 2000; 14 272 276
42. Kisters K., Spieker C., Tepel M. et al. New data about the effects of oral physiological magnesium supplementation on several risk factors (lipids and blood pressure). Magnes Res: 1993; 6 355 360
43. Von Ehrlich B., Wadepuhl M. Erhöhtes Risiko einer diabetischen Retinopathie bei niedrigem Serum-Magnesium. Diabetes und Stoffwechsel: 2003; 12 285 289
44. De Leeuw I., Engelen W., De Block C. et al. Long term magnesium supplementation influences favourably the natural evolution of neuropathy in Mg-depleted type 1 diabetic patients (T1dm). Magnes Res: 2004; 17 109 114 (Pubitemid 39107245)
45. Engelen W., Bouten A., De Leeuw I. et al. Are low magnesium levels in type 1 diabetes associated with electromyographical signs of polyneuropathy? Magnes Res: 2000; 13 197 203
46. Lima M., Cruz T., Pousada J. C. et al. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes card: 1998; 21 682 686 (Pubitemid 28487055)
47. Pham P. C., Pham P. M., Pham P. T. Patients with diabetes mellitus type 2 and hypomagnesemia may have enhanced glomerular filtration via hypocalcemia. Clin Nephrol: 2012; 78 442 448
48. Prabodh S., Prakash D. SRS, Sudhakar G. et al. Status of copper and magnesium levels in diabetic nephropathy cases: a case-control study from south india. Biol Trace Elem Res: 2011; 142 29 35
49. Pham P. C., Pham P. M., Pham P. T. et al. The link between lower serum magnesium and kidney function in patients with diabetes mellitus type 2 deserves a closer look. Clin Nephrol: 2009; 71 375 379
50. Pham P. CT, Pham P. MT, Pham P. AT et al. Lower serum magnesium levels are associated with more rapid decline of renal function in patients with diabetes mellitus type 2. Clin Nephrol: 2005; 63 429 436
51. Barragan-Rodriguez L., Rodriguez-Moran M., Guerrero-Romero F. Depressive symptoms and hypomagnesemia in older diabetic subjects. Arch Med Res: 2008; 38 752 756
52. Barragan-Rodriguez L., Rodriguez-Moran M., Guerrero-Romero F. Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial. Magnes Res: 2008; 21 218 223
53. Vierling W., Liebscher D. H., Micke O. et al. Magnesiummangel und Magnesiumtherapie bei Herzrhythmusstörungen. Dtsch Med Wochenschr: 2013; 138 1165 1171
54. Classen H. G., Gröber U., Kisters K. Magnesium-Mangel und Arzneimittel. MMP: 2012; 35 274 280
55. Curiel-Garcia J. A., Rodriguez-Moran M., Guerrero-Romero F. Hypomagnesemia and mortality in patients with type 2 diabetes. Magnes Res: 2008; 21 163 166
56. Spätling L., Classen H. G., Külpmann W. R. et al. Diagnostik des Magnesiummangels. Fortschritte der Medizin: 2000; 118 49 53
57. Atsmon J., Doley E. Drug-induced hypomagnesaemia: scope and management. Drug Saf: 2005; 28 763 788 (Pubitemid 41428551)
58. Ismail Y., Ismail A. A., Ismail A. AA. The underestimated problem of using serum magnesium measurements to exclude magnesium deficiency in adults; a health warning is needed for normal results. Clin Chem Lab Med: 2010; 48 323 327
59. Porta S., Gell H., Porta J. et al. Evidence of progress and success of Magnesium substitution by correlating Mg dynamics and metabolic parameters. Trace Elements and Electrolytes: 2013; 30 87 93
60. Altura B. T., Burack J. L., Cracco R. Q. et al. Clinical studies with the NOVA ISE for IMg2+. Scand J Clin Lab Invest Suppl: 1994; 217 53 67 (Pubitemid 24231811)
61. Resnick L. M., Altura B. T., Bupta R. K. et al. Intracellular and extracellular magnesium depletion in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia: 1993; 36 767 770 (Pubitemid 23218646)
62. Cunningham J., Rodriguez M., Messa P. Magnesium in chronic kidney disease stages 3 and 4 and in dialysis patients. Clin Kidney J: 2012; 5 01 i39 i59